LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
Rezumat
Modificarea prețului
24h
Curent
Minim
82.94
Maxim
83.26
Recomandări | Puternic Cumpărare |
---|---|
Prognoză pe 12 luni | +6.27 upside |
Scor tehnic
By Trading Central
Încredere
Very Strong Bearish Evidence
82.46 / 87.21 Suport & Rezistență
AstraZeneca PLC ADR Grafic
Știri relevante
25 iul. 2024, 09:17 UTC
AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update
DJ
Citește
25 iul. 2024, 06:48 UTC
AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations
DJ
Citește
12 iul. 2024, 19:57 UTC
Instil Bio Shares Surge Following Rental Agreement with AstraZeneca
DJ
Citește
5 sept. 2024, 13:00 UTC
China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ
DJ
Citește
29 iul. 2024, 10:30 UTC
Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ
DJ
Citește
25 iul. 2024, 13:20 UTC
AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD
DJ
Citește
25 iul. 2024, 09:21 UTC
AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk
DJ
Citește
25 iul. 2024, 07:05 UTC
AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk
DJ
Citește
25 iul. 2024, 06:06 UTC
AstraZeneca Increased Interim Dividend by 7c to $1.00
DJ
Citește
25 iul. 2024, 06:04 UTC
AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range
DJ
Citește
25 iul. 2024, 06:04 UTC
AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range
DJ
Citește
25 iul. 2024, 06:04 UTC
AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency
DJ
Citește
25 iul. 2024, 06:04 UTC
AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency
DJ
Citește
25 iul. 2024, 06:03 UTC
AstraZeneca Raises 2024 View
DJ
Citește
25 iul. 2024, 06:02 UTC
AstraZeneca 2Q Revenue Consensus Was $12.7B
DJ
Citește
25 iul. 2024, 06:02 UTC
AstraZeneca 2Q Core EPS Consensus Was $1.95
DJ
Citește
25 iul. 2024, 06:00 UTC
AstraZeneca PLC 2Q Adj EPS $1.98
DJ
Citește
25 iul. 2024, 06:00 UTC
AstraZeneca PLC 2Q Pretax Pft $2.4B
DJ
Citește
25 iul. 2024, 06:00 UTC
AstraZeneca PLC 2Q Rev $12.94B
DJ
Citește
25 iul. 2024, 06:00 UTC
AstraZeneca PLC 2Q Oper Pft $2.75B
DJ
Citește
25 iul. 2024, 06:00 UTC
AstraZeneca PLC 2Q Net Pft $1.93B
DJ
Citește
25 iul. 2024, 06:00 UTC
AstraZeneca PLC 2Q EPS $1.24
DJ
Citește
15 iul. 2024, 06:04 UTC
AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone
DJ
Citește
15 iul. 2024, 06:04 UTC
AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone
DJ
Citește
15 iul. 2024, 06:02 UTC
AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing
DJ
Citește
15 iul. 2024, 06:02 UTC
AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B
DJ
Citește
15 iul. 2024, 06:01 UTC
AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline
DJ
Citește
15 iul. 2024, 06:00 UTC
AstraZeneca Completes Acquisition of Amolyt Pharma
DJ
Citește
15 iul. 2024, 06:00 UTC
AstraZeneca PLC Acquisition of Amolyt Pharma completed
DJ
Citește
15 iul. 2024, 06:00 UTC
AstraZeneca PLC Acquisition of Amolyt Pharma completed
DJ
Citește
Comparație
Modificare preț
AstraZeneca PLC ADR Așteptări
Obiectiv de preț
By TipRanks
Prognoză pe 12 luni
Medie 88.26 USD 6.27%
Maxim 99 USD
Minim 74 USD
În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAstraZeneca PLC ADR - Dist în ultimele 3 luni.
Consens privind evaluarea
By TipRanks
Puternic Cumpărare
6 ratings
5
Cumpărare
1
Păstrare
0
Vânzare
Ținând cont de 6 analiști care au acordat evaluări ale acțiunilor AstraZeneca PLC ADR - Dist în ultimele 3 luni.
Scor tehnic
By Trading Central
Termen scurt
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Termen mediu
Bearish Evidence
Recent bearish events outweigh bullish events.
Termen lung
No Evidence
There are no events.